Olympic Gold Medalist Champions New Goal: Getting Kids into Sports Programs
In 1984, Benita Fitzgerald Mosley won gold at the 1984 Olympics. Now, the former Olympian is the CEO of Laureus USA and is on a mission to bring sports to under-served kids across the U.S.
Laureus USA works in cities to bring free sports programs to kids. Mosley explains that the programs also include mentoring, college counseling, and other development tools.
Mosley says one of the greatest obstacles preventing kids from getting into sports programs in the cost barrier. She also acknowledges the performance barrier due to the professionalism of kid sports. With college scholarships and other opportunities on the line, elite and expensive training programs are keeping some kids out.
When asked about what it is like to win a gold medal at the Olympics, Mosley compared it to being a 5 year-old on Christmas morning. She said she still cries whenever the national anthem plays for a fellow American athlete.
The Week's Top Stories is a guided tour through the biggest market stories of the week, from winning stocks to brutal dips to the facts and forecasts generating buzz on Wall Street.
Federal Reserve Chair Jerome Powell was tricked into an extended phone call in January with Russian pranksters posing as Ukrainian President Volodymyr Zelenskyy, during which Powell appeared to discuss the economic impact of interest rate hikes.
Amazon on Thursday reported stronger-than-expected revenue and profits for the first quarter, sending its stocks higher in after-hours trading. But its prices took a dip in the evening amid concerns about a continued slowdown in the company's profitable cloud computing unit AWS.
A key index of underlying inflation that is closely followed by the Federal Reserve remained elevated last month, keeping the Fed on track to raise interest rates next week for the 10th time since March of last year.
As a growing number of overweight Americans clamor for Ozempic and Wegovy — drugs touted by celebrities and on TikTok to pare pounds — an even more powerful obesity medicine is poised to upend treatment.
